JESFAMI
Live / Registered — Registered (as of 17 Jun 2025)
What this means for you
Registered since 17 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79393685
- Registration number
- 7830527
- Mark type
- Stylized text
- Filed
- 05 Feb 2024
- Published for opposition
- 29 Apr 2025
- Registered
- 17 Jun 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations for the treatment of dermatological diseases; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in the treatment of hematology diseases; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in the treatment of ophthalmology diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
- Class 044 — Medical, beauty and agricultural services: Collection and preservation of human blood; Collection and preservation services for tissue and cells, namely, collection and banking of umbilical cord tissue perivascular stem cells; medical diagnostic services; medical treatment services being medical analysis services relating to the treatment of patients; provision of medical information and remote monitoring of medical data for medical diagnosis and medical treatment
Owner
- Novartis AG, CH
- Novartis AG, CH
- Novartis AG, CH
Prosecution history
- 29 Jan 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Jan 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 14 Jan 2026 — FINAL DISPOSITION PROCESSED
- 03 Oct 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 17 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Sept 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Sept 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 17 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE